Procalcitonin-guided antibiotic prescription in patients with respiratory syncytial virus and influenza virus
Lisa Hessels, Didi Vossen, Miriam Leeuw, Nienke Paternotte, Dian Karssen, Tony Chiang, Lotte Terpstra, Wim Boersma · 2025
Read Procalcitonin-guided antibiotic prescription in patients with respiratory syncytial virus and influenza virus by Lisa Hessels, Didi Vossen, Miriam Leeuw, Nienke Paternotte, Dian Karssen, Tony Chiang, Lotte Terpstra, Wim Boersma (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12699590.txt.
Description
Lisa Hessels and co-authors (2025) ask whether a blood marker can stop antibiotics being wasted on viral infections. Patients with influenza or RSV often receive antibiotics, in case bacteria are present, driving resistance and side effects. The marker is procalcitonin, which rises more in bacterial than viral illness. The team reviewed 558 influenza and 175 RSV patients from 2017 to 2024. Wards that dosed by the marker were compared with wards using clinical judgment alone.
Outcomes included how many patients got antibiotics, total dose, and days of treatment, plus safety measures like readmission and death. At admission, about half of influenza patients received antibiotics in both groups, 49.6 percent under judgment and 53.2 under the marker, a difference that adjustment shows is not meaningful. The paper examines the full course, where guidance may matter more than at the door. Stewardship needs evidence like this before a biomarker earns routine use.
Catalog record
| CREATOR | Lisa Hessels, Didi Vossen, Miriam Leeuw, Nienke Paternotte, Dian Karssen, Tony Chiang, Lotte Terpstra, Wim Boersma |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |